Troxerutin DAB

Troxerutin DAB is a premium-grade, yellow to yellowish-green crystalline powder trihydroxyethylrutoside flavonol compound carrying CAS number 7085-55-4. Processed under strict German Pharmacopoeia (DAB) compliance, this high-purity phlebotonic active substance exhibits exceptional capillary permeability reduction efficiency and reliable molecular matrix stability, making it an ideal core choice for manufacturing clinical-strength venotonic gels, advanced chronic venous insufficiency tablets, and modern vascular research lines globally.

SKU: 7085-55-4 Category: Tag:
Description
Troxerutin DAB represents an elite-grade hydroxyethylrutoside bioflavonoid active substance refined under strict molecular quality guidelines to fulfill advanced clinical compounding and vasoprotective drug standards.
Zyntex supplies high-purity Troxerutin DAB (CAS 7085-55-4) tailored specifically for global pharmaceutical manufacturing plants, cardiovascular research laboratories, and international nutraceutical synthesis loops.
Functioning as a highly specific capillary resistance booster and erythrocyte aggregation regulator, it delivers precise substance profiles that ensure uniform dry batch integration and highly predictable dissolution kinetics in topical gel matrices. Furthermore, its strictly minimized chemical volatile impurities and tight compliance with German Pharmacopoeia protocols make it an ideal selection for sensitive oral solid dose compression and continuous venotonic fluid production. Accordingly, formulation scientists specify this active substance to stabilize modern flavonol carriers and maintain exact potency integrity across continuous processing cycles.

Venous Microcirculation Regulation and Topical Vehicle Stability

Excellent crystalline solubility performance and outstanding endothelial cell membrane affinity provide a distinct operational edge when engineering modern fast-acting vascular protection formulations. This active pharmaceutical solid operates by blocking endothelial cell structural decay and neutralizing localized oxidative free radicals to break down microvascular permeability setups, supplying the exact chemical mechanisms required to induce rapid edema clearance without altering raw gel base uniformity. It assists compounding engineers in maintaining strict active concentration uniformity across high-speed emulsification and tube filling lines, mitigating trace sedimentation risks within automated volumetric dosing machinery. For instance, specialized pharmaceutical facilities incorporate this refined rutoside derivative powder as a core active component in targeted varicose vein relief ointment batches. As a consequence, it maximizes the technical throughput of automated pressurized packaging machinery and continuous quality assurance checks. Consequently, Zyntex coordinates clean room crystallization paths to eliminate downstream moisture-induced potency drops from your factory schedule.

In addition to this, Zyntex coordinates climate-controlled logistics for pilot-scale manufacturing operations and advanced angiology drug development centers. The compound maintains its refined bioflavonoid integrity under strict storage parameters, preventing light-induced chemical breakdown or thermal degradation during automated mechanical blending steps. It advances contemporary medical engineering by providing a thoroughly analyzed, highly predictable phlebotonic raw material that meets international monograph standards. Simultaneously, it remains a critical chemical standard for routine high-performance liquid chromatography (HPLC) compound calibration assays and spectrophotometric validation testing loops. In brief, our product functions as a dependable chemical foundation, supporting both the performance of commercial clinical batches and the analytical rigor of specialized industrial laboratories.

Primary Medical Sectors for Troxerutin DAB

This high-purity crystalline active drug compound delivers crucial technical value within these four primary industrial sectors:

🧴 Phlebotonic Gels

Primary topical active source used for formulating high-adhesion hydrogels targeted at hemorrhoidal and varicose vein symptom management. Hence, it directly supports optimal micro-dispersion control lines.

💊 Venotonic Tablets

Utilized as a high-purity active base to compound professional oral solid doses designed for long-term capillary fragile relief loops. Clearly, it is key for uniform dissolving patterns.

🔬 Endothelial Assays

Acts as an essential reference active standard for monitoring microvascular filtration kinetics, assay calibration, and routine laboratory diagnostics. Resultantly, it guarantees excellent matrix clarity.

🏢 Angiology Research

Used as a professional active component for validating advanced anti-inflammatory enzyme blocks and specialized liposomal targeted vascular delivery loops. Specifically, it confirms optimal reaction pathways.

Technical Specifications

ParameterStandard Value
Product NameTroxerutin DAB (Trihydroxyethylrutoside)
Standard GradeDeutsches Arzneibuch (DAB Compliance)
Assay / Purity (HPLC)95.0% to 105.0% (calculated as anhydrous active substance)
AppearanceYellow or yellowish-green crystalline powder
SolubilitySoluble in water; slightly soluble in ethanol; practically insoluble in chloroform
CAS Number7085-55-4

Safety & Handling (LOW RISK / BIOCAMPATIBLE FLAVONOL): Troxerutin DAB is a highly stable, non-hazardous bioflavonoid derivative exhibiting excellent safety profiles and biological compatibility. Under standard manufacturing process setups, it does not pose acute dermal toxicity, chemical corrosion, or localized systemic organ hazards. Therefore, store comfortably inside original light-resistant airtight containment packaging systems within a cool, thoroughly dry, and properly ventilated warehouse facility protected from extreme direct heat or intense solar exposure to maintain absolute chemical framework stability. Keep container structures tightly sealed when not dispensing to avoid physical moisture absorption. Standard good industrial handling configurations—including protective working gloves, clean room safety glasses, and general dust tracking clothing—are entirely sufficient to sustain complete operational safety during all scaling phases. Review the Safety Data Sheet (SDS).